These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [Evolution of antibiograms of bacilli persisting under treatment in the sanatorium]. Marion L. Rev Tuberc Pneumol (Paris); 1967; 31(6):785-808. PubMed ID: 4317451 [No Abstract] [Full Text] [Related]
36. [Studies on the susceptibility of secondary anti-tuberculosis drugs (with special reference to the resistance-stabilities of cycloserine and ethionamide-resistant bacilli)]. Hayashi S. Kumamoto Igakkai Zasshi; 1970 Feb 25; 44(2):135-43. PubMed ID: 4986047 [No Abstract] [Full Text] [Related]
37. [Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis]. Mkrtchian SV, Ushkin VV. Antibiotiki; 1971 May 25; 16(5):472-7. PubMed ID: 5002224 [No Abstract] [Full Text] [Related]
38. [Resistance of tubercle bacilli to cycloserine, viomycin and ethionamide in patients suffering from pulmonary tuberculosis]. Srednicka-Zajac D, Mysakowska H, Szarewicz-Adamczyk W, Litwin B. Ann Univ Mariae Curie Sklodowska Med; 1967 May 25; 22():71-8. PubMed ID: 4308440 [No Abstract] [Full Text] [Related]